News Releases and Coverage

The Canadian HIV Trials Network receives $22.85M (CHÉOS, PHCRI, BCCSU)

(L-R): Dr. Michael Allard, Dr. Jeannie Shoveller, Dr. Aslam Anis, The Honourable Hedy Fry, Dr. Melanie Murray, Darren Lausher (Community Advisory Committee, CTN).
(L-R): Dr. Michael Allard, Dr. Jeannie Shoveller, Dr. Aslam Anis, The Honourable Hedy Fry, Dr. Melanie Murray, Darren Lausher (Community Advisory Committee, CTN).

The Government of Canada, through the Canadian Institutes of Health Research (CIHR), is investing $22.85 million for AIDS/HIV research in the CIHR Canadian HIV Trials Network (CTN). The CTN’s National Centre is hosted by the Centre for Health Evaluation and Outcomes Sciences (CHÉOS), and is supported by the faculty of medicine at UBC, Providence Health Care and Providence Health Care Research Institute (PHCRI).

Hedy Fry, member of parliament for Vancouver Centre, made the announcement on June 26, 2019, on behalf of Ginette Petitpas Taylor, Minister of Health.

“Investments in HIV research are essential to continuing the creation of scientific knowledge that will translate into the most effective prevention strategies and treatment for Canadians living with and affected by HIV,” Fry said. “The recipients being celebrated today should be proud of their work as it holds tremendous potential to save lives. Thank you for your innovative approaches and to building a healthier Canada.”

Dr. Jeannie Shoveller, a professor in the faculty of medicine’s school of population and public health, research director of the BC Centre on Substance Use (BCCSU), and the first woman to be named chairperson of CIHR’s Governing Council, also spoke to the importance of the investment.

Read more on UBC News.

Give us your comments and story ideas

X